Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 139

1.

Cerebrospinal fluid neopterin: an informative biomarker of central nervous system immune activation in HIV-1 infection.

Hagberg L, Cinque P, Gisslen M, Brew BJ, Spudich S, Bestetti A, Price RW, Fuchs D.

AIDS Res Ther. 2010 Jun 3;7:15. doi: 10.1186/1742-6405-7-15.

2.

Immune activation of the central nervous system is still present after >4 years of effective highly active antiretroviral therapy.

Edén A, Price RW, Spudich S, Fuchs D, Hagberg L, Gisslén M.

J Infect Dis. 2007 Dec 15;196(12):1779-83. doi: 10.1086/523648.

3.

Cerebrospinal fluid viral load, intrathecal immunoactivation, and cerebrospinal fluid monocytic cell count in HIV-1 infection.

Gisslén M, Fuchs D, Svennerholm B, Hagberg L.

J Acquir Immune Defic Syndr. 1999 Aug 1;21(4):271-6.

PMID:
10428104
4.

CSF neurofilament protein (NFL) -- a marker of active HIV-related neurodegeneration.

Abdulle S, Mellgren A, Brew BJ, Cinque P, Hagberg L, Price RW, Rosengren L, Gisslén M.

J Neurol. 2007 Aug;254(8):1026-32. Epub 2007 Apr 10.

PMID:
17420923
5.

Low levels of HIV-1 RNA detected in the cerebrospinal fluid after up to 10 years of suppressive therapy are associated with local immune activation.

Dahl V, Peterson J, Fuchs D, Gisslen M, Palmer S, Price RW.

AIDS. 2014 Sep 24;28(15):2251-8. doi: 10.1097/QAD.0000000000000400.

6.

Continuing intrathecal immunoactivation despite two years of effective antiretroviral therapy against HIV-1 infection.

Abdulle S, Hagberg L, Svennerholm B, Fuchs D, Gisslén M.

AIDS. 2002 Nov 8;16(16):2145-9.

PMID:
12409735
7.

Persistent intrathecal immune activation in HIV-1-infected individuals on antiretroviral therapy.

Yilmaz A, Price RW, Spudich S, Fuchs D, Hagberg L, Gisslén M.

J Acquir Immune Defic Syndr. 2008 Feb 1;47(2):168-73.

8.

Cerebrospinal fluid signs of neuronal damage after antiretroviral treatment interruption in HIV-1 infection.

Gisslén M, Rosengren L, Hagberg L, Deeks SG, Price RW.

AIDS Res Ther. 2005 Aug 18;2:6.

9.

Cerebrospinal fluid neopterin in paediatric neurology: a marker of active central nervous system inflammation.

Dale RC, Brilot F, Fagan E, Earl J.

Dev Med Child Neurol. 2009 Apr;51(4):317-23. doi: 10.1111/j.1469-8749.2008.03225.x. Epub 2009 Jan 26.

10.

Cerebrospinal fluid neopterin concentrations in central nervous system infection.

Hagberg L, Dotevall L, Norkrans G, Larsson M, Wachter H, Fuchs D.

J Infect Dis. 1993 Nov;168(5):1285-8.

PMID:
8228365
11.

Cerebrospinal fluid interferon-gamma-inducible protein 10 (IP-10, CXCL10) in HIV-1 infection.

Cinque P, Bestetti A, Marenzi R, Sala S, Gisslen M, Hagberg L, Price RW.

J Neuroimmunol. 2005 Nov;168(1-2):154-63. Epub 2005 Aug 8.

PMID:
16091292
12.

Cerebrospinal fluid viral load in HIV-1-infected patients without antiretroviral treatment: a longitudinal study.

Gisslén M, Hagberg L, Fuchs D, Norkrans G, Svennerholm B.

J Acquir Immune Defic Syndr Hum Retrovirol. 1998 Apr 1;17(4):291-5.

PMID:
9525428
13.
14.

Failure of atorvastatin to modulate CSF HIV-1 infection: results of a pilot study.

Probasco JC, Spudich SS, Critchfield J, Lee E, Lollo N, Deeks SG, Price RW.

Neurology. 2008 Aug 12;71(7):521-4. doi: 10.1212/01.wnl.0000325006.84658.e7.

15.

Intrathecal immune activation is associated with cerebrospinal fluid markers of neuronal destruction in AIDS patients.

Hagberg L, Fuchs D, Rosengren L, Gisslén M.

J Neuroimmunol. 2000 Jan 3;102(1):51-5.

PMID:
10626666
16.

Cerebrospinal fluid levels of chemokines in HIV infected patients with and without opportunistic infection of the central nervous system.

Christo PP, Vilela Mde C, Bretas TL, Domingues RB, Greco DB, Livramento JA, Teixeira AL.

J Neurol Sci. 2009 Dec 15;287(1-2):79-83. doi: 10.1016/j.jns.2009.09.002. Epub 2009 Sep 25.

PMID:
19782379
17.

Expansion of neopterin and beta 2-microglobulin in cerebrospinal fluid reaches maximum levels early and late in the course of human immunodeficiency virus infection.

Bogner JR, Junge-Hülsing B, Kronawitter U, Sadri I, Matuschke A, Goebel FD.

Clin Investig. 1992 Aug;70(8):665-9.

PMID:
1392442
18.

Serum and cerebrospinal fluid levels of soluble intercellular adhesion molecule 1 (sICAM-1) in patients with HIV-1 associated neurological diseases.

Heidenreich F, Arendt G, Jander S, Jablonowski H, Stoll G.

J Neuroimmunol. 1994 Jul;52(2):117-26.

PMID:
7913474
19.

Neopterin concentrations in cerebrospinal fluid and serum of individuals infected with HIV-1.

Fuchs D, Chiodi F, Albert J, Asjö B, Hagberg L, Hausen A, Norkrans G, Reibnegger G, Werner ER, Wachter H.

AIDS. 1989 May;3(5):285-8. Erratum in: AIDS 1989 Jun;3(6):following A92.

PMID:
2504232
20.

Increased activity of matrix metalloproteinases in the cerebrospinal fluid of patients with HIV-associated neurological diseases.

Liuzzi GM, Mastroianni CM, Santacroce MP, Fanelli M, D'Agostino C, Vullo V, Riccio P.

J Neurovirol. 2000 Apr;6(2):156-63.

PMID:
10822329
Items per page

Supplemental Content

Write to the Help Desk